CCS Cell Culture Service celebrates its 10th anniversary

Hamburg, (PresseBox) - CCS Cell Culture Service GmbH, which was founded in early 2000 by the Hamburg scientist Dr. Oliver Klotzsche and his three partners, was originally dedicated to provide all kinds of cell culture related services. Within the last decade the company has advanced to one of the leading suppliers of cells and cell based reagents for pharmaceutical industries. Meanwhile CCS has 20 employees. Last year CCS launched its subsidiary at the east coast of the USA and has thereby opened a new chapter in the book of its success.

The jubilee has been recently celebrated with international guests for industries and academia. Hans-Dieter Schubert, since many years senior scientist in the department of lead discovery of Boehringer Ingelheim Pharma GmbH & Co KG, has given a comprising overview about how new drug entities are developed today and in the past. In the evening the party was ended with an outdoor barbecue in the atrium of the Centre for Innovative Medicine. In his speech Dr. Klotzsche recalled encounters with people who were of particular importance for the development of the company. However, his major gratefulness was dedicated to the employees of CCS. "Without their engagement and trust, CCS would never have achieved its goals", he said.

CCS Cell Culture Service GmbH

CCS is dedicated to improving the output of drug discovery research by providing custom made cell based reagents. For more than ten years, CCS has been supporting the research departments of pharmaceutical and biotechnology companies in their efforts to discover new drug entities. CCS is one of the leading custom suppliers of recombinant cell lines, assayready frozen cells, qualified membranes and proteins for highthroughputscreening. Major pharmaceutical companies all over Europe and the USA now rely on the custom products and services of CCS.

Diese Pressemitteilungen könnten Sie auch interessieren

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.

Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.